Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [(11)C]ABP688

The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in the pathophysiology of mood and anxiety disorders and is a potential treatment target in major depressive disorder (MDD). This study compared brain mGluR5 binding in elderly patients suffering from MDD with that in elderly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Psychiatry
Autors principals: DeLorenzo, C, Sovago, J, Gardus, J, Xu, J, Yang, J, Behrje, R, Kumar, J S D, Devanand, D P, Pelton, G H, Mathis, C A, Mason, N S, Gomez-Mancilla, B, Aizenstein, H, Mann, J J, Parsey, R V
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5068588/
https://ncbi.nlm.nih.gov/pubmed/26645628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2015.189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars